To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Strain ID |
Strain Descriptor |
Associated gene(s) |
Phenotypes |
| DBS0235412 | 1C7 | gp130 | decreased cell-substrate adhesion, delayed development, increased growth rate |
| DBS0235413 | 24EH6 | racE | abolished cytokinesis |
| DBS0235414 | 2F5 | gp130 | decreased cell-substrate adhesion, delayed development, increased growth rate |
| DBS0238601 | 5NT- | 5NT | delayed tip formation, multiple tips in culminant, multiple tips in mound |
| DBS0235584 | CF45-1- | cf45-1 | decreased aggregate size, decreased cell motility, increased aggregate size, increased cell-cell adhesion, increased intracellular glucose level |
| DBS0235585 | CF50- | cf50-1 | decreased extracellular counting factor component(s) level, increased aggregate size, increased cell-cell adhesion, increased gene expression, increased protein level |
| DBS0235612 | CMFR1- | cmfB | abolished aggregation, decreased gene expression |
| DBS0235596 | ChLim- | ChLim | increased growth rate, increased phagocytosis |
| DBS0252637 | DAip1- | DAip1 | decreased growth rate, decreased phagocytosis, decreased pinocytosis, delayed cytokinesis |
| DBS0235659 | DD3-3- | DD3-3 | decreased gene expression, precocious aggregation |
| DBS0236049 | DDB_G0268012- | DDB_G0268012 | wild type |
| DBS0236046 | DDB_G0268158- | DDB_G0268158 | wild type |
| DBS0236039 | DDB_G0268678- | DDB_G0268678 | wild type |
| DG1007 | DDB_G0269232- | DDB_G0269232 | abolished culmination |
| DBS0236025 | DDB_G0270366- | DDB_G0270366 | wild type |
| DBS0236026 | DDB_G0270368- | DDB_G0270368 | wild type |
| DBS0236036 | DDB_G0270744- | DDB_G0270744 | wild type |
| DBS0236043 | DDB_G0276221- | DDB_G0276221 | wild type |
| DBS0236042 | DDB_G0276689- | DDB_G0276689 | wild type |
| DBS0236041 | DDB_G0277179- | DDB_G0277179 | wild type |
| DBS0236045 | DDB_G0277575- | DDB_G0277575 | wild type |
| DBS0236044 | DDB_G0278315- | DDB_G0278315 | wild type |
| DBS0236038 | DDB_G0279005- | DDB_G0279005 | wild type |
| DBS0236032 | DDB_G0279163- | DDB_G0279163 | wild type |
| DBS0236033 | DDB_G0279163- | DDB_G0279163 | wild type |
| DBS0236028 | DDB_G0279609- | DDB_G0279609 | wild type |
| DBS0236029 | DDB_G0279609- | DDB_G0279609 | wild type |
| DBS0236035 | DDB_G0280481- | DDB_G0280481 | wild type |
| DBS0236019 | DDB_G0281735- | DDB_G0281735 | wild type |
| DBS0236020 | DDB_G0281735- | DDB_G0281735 | wild type |
| DBS0236027 | DDB_G0290225- | DDB_G0290225 | wild type |
| DG1003 | DDB_G0291992- | DDB_G0291992 | aberrant culminant morphology |
| DBS0236037 | DDB_G0292186- | DDB_G0292186 | wild type |
| DBS0236023 | DDB_G0293116- | DDB_G0293116 | wild type |
| DBS0236024 | DDB_G0293116- | DDB_G0293116 | wild type |
| DBS0236030 | DDB_G0293762- | DDB_G0293762 | wild type |
| DG1039 | DG1039- | DDB_G0284037 | aberrant fruiting body morphology |
| DG1040 | DG1040- | DDB_G0276029 | aberrant fruiting body morphology |
| DG1041 | DG1041- | DDB_G0269126 | aberrant fruiting body morphology |
| DG1054 | DG1054- | DDB_G0277719 | aberrant fruiting body morphology |
| DG1060 | DG1060- | DDB_G0281953 | aberrant fruiting body morphology |
| DG1062 | DG1062- | DDB_G0286351 | aberrant fruiting body morphology |
| DG1074 | DG1074- | DDB_G0272108 | aberrant fruiting body morphology |
| DG1080 | DG1080- | DDB_G0281559 | aberrant fruiting body morphology |
| DG1091 | DG1091- | DG1091 | decreased fruiting body size |
| DG1098 | DG1098- | DG1098 | decreased fruiting body size |
| DG1104 | DG1104- | DDB_G0283535 | abolished aggregation |
| DG1105 | DG1105- | DG1105 | abolished aggregation |
| DG1106 | DG1106- | DG1106 | abolished aggregation |
| DG1110 | DG1110- | DDB_G0269128 | aberrant fruiting body morphology |
| DG1112 | DG1112- | DG1112 | decreased stalk width |
| DG1113 | DG1113- | DG1113 | increased stalk length |
| DG1122 | DG1122- | DG1122 | aberrant fruiting body morphology |
| DG1124 | DG1124- | DG1124 | development arrests at loose aggregate stage |
| DG2033 | DG2033- | DG2033 | development arrests at mound stage |
| DG2044 | DG2044- | DG2044 | development arrests at loose aggregate stage |
| DBS0266700 | Dd5P1- | Dd5P1 | wild type |
| DBS0235660 | Dd5P2- | Dd5P2 | increased basal F-actin level, wild type |
| DBS0266702 | Dd5P3- | Dd5P3 | wild type |
| DBS0266692 | Dd5P4- | Dd5P4 | decreased engulfment during phagocytosis, decreased growth rate, decreased phagocytosis, multiple tips in mound |
| DBS0266693 | Dd5P4-/ [act15]: Dd5P4 | Dd5P4 | wild type |
| DBS0266719 | Dd5P4-/ [act15]: Dd5P4: GFP | Dd5P4 | wild type |
| DBS0266695 | Dd5P4-/ [act15]: GAP5P4 | Dd5P4 | decreased growth rate, multiple tips in mound |
| DBS0266720 | Dd5P4-/ [act15]: Hs-OCRL | Dd5P4 | decreased phagocytosis |
| DBS0266721 | Dd5P4-/ [act15]: Hs-OCRL(D422A) | Dd5P4 | decreased phagocytosis |
| DBS0266694 | Dd5P4-/ [act15]: cat5P4 | Dd5P4 | decreased growth rate, multiple tips in mound |
| DBS0235940 | EB1- | eb1 | aberrant mitosis |
| DBS0236015 | GEG04K11 (tmcB- in KAX3) | tmcB | aberrant aggregation during macrocyst formation, increased number of peripheral cells during sexual reproduction, small macrocysts |
| DBS0236016 | GEG04V12 (tmcB- in V12) | tmcB | aberrant aggregation during macrocyst formation, increased number of peripheral cells during sexual reproduction, small macrocysts |
| DBS0236017 | GEG10K23 (tmcC- in KAX3) | tmcC | aberrant aggregation during macrocyst formation, increased number of peripheral cells during sexual reproduction |
| DBS0236018 | GEG10V03 (tmcC- in V12) | tmcC | aberrant aggregation during macrocyst formation, increased number of peripheral cells during sexual reproduction |
| DBS0302603 | GFP: disgorgin/ disgorgin- | DDB_G0280955 | wild type |
| DBS0302615 | GFP: phgA(1-274: 283-438)/ phgA- | phgA | aberrant response to hypo-osmotic stress |
| DBS0302614 | GFP: phgA/ phgA- | phgA | wild type |
| DBS0236085 | GP138C- | cfrC | wild type |
| HTY506 | HTY506 | pkaR | aberrant fruiting body morphology, aberrant spore morphology, decreased phosphorylation of actin, decreased spore viability, increased sporulation, precocious development |
| DBS0236716 | PAKc- | pakC | decreased chemotaxis rate, decreased lateral pseudopod suppression |
| DBS0236779 | PIPkinA- | pik6 | abolished aggregation, decreased gene expression |
| DBS0236783 | PKAcat- | pkaC | abolished aggregation |
| DBS0236840 | R7 | nosA | development arrests at mound stage |
| DBS0236900 | RIP3 | ripA | abolished activation of adenylate cyclase, abolished aggregation, decreased cell polarity, decreased chemotaxis rate, decreased myosin II assembly |
| DBS0236996 | TL26 | cotB | aberrant spore coat morphology |
| DBS0304456 | [AS]alrA/ gcsA- | alrA, gcsA | cell cycle arrest, decreased growth rate in suspension |
| DBS0236827 | [AS]proA/ proB- | proA, proB | aberrant cytokinesis, abolished growth, decreased cell motility, development arrests at slug stage, increased basal F-actin level |
| DBS0238036 | [AS]proA/ proB-/ [act15]: proA | proA, proB | wild type |
| DBS0238037 | [AS]proA/ proB-/ [act15]: proB | proA, proB | wild type |
| DBS0302602 | [OE]: disgorgin(Delta-Fbox)/ disgorgin- | DDB_G0280955 | wild type |
| DBS0302601 | [OE]: disgorgin(Q551A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0302600 | [OE]: disgorgin(R515A)/ disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis |
| DBS0302599 | [OE]: disgorgin/ disgorgin- | DDB_G0280955 | wild type |
| DBS0302610 | [OE]: disgorgin/ phgA- | DDB_G0280955, phgA | aberrant contractile vacuole organization and biogenesis |
| DBS0302611 | [OE]: phgA/ disgorgin- | DDB_G0280955, phgA | aberrant contractile vacuole organization and biogenesis |
| DBS0302656 | [act15]: cnrN/ cnrN- | cnrN | wild type |
| DBS0302658 | [act15]: cnrN/ smlA- | cnrN, smlA | decreased fruiting body size |
| DBS0304457 | [act15]: sodA/ gcsA- | gcsA, sodA | wild type |
| DBS0304460 | [act]: alrA/ gcsA- | alrA, gcsA | wild type |
| HAD186 | aarA- | aarA | aberrant fruiting body morphology, decreased sporulation |
| DBS0266687 | abiA- | abiA | aberrant cytokinesis, aberrant protein localization, decreased chemotaxis to folate, decreased growth rate, decreased protein level |
| DBS0266688 | abiA- | abiA | aberrant protein localization |
| DBS0305672 | abpB- | abpB | increased filopodium formation |
| DBS0236077 | abpC- | abpC | aberrant phototaxis, aberrant thermotaxis |
| DBS0237938 | abpC-/ [act15]: GFP: abpC(9-148) | abpC | aberrant phototaxis |
| DBS0235426 | abpC-/ [act15]: abpC | abpC | wild type |
| DBS0237945 | abpC-/ [act15]: abpC(1-348: 449-857): GFP | abpC | aberrant F-actin organization, aberrant phototaxis |
| DBS0237946 | abpC-/ [act15]: abpC(1-556: 644-857): GFP | abpC | aberrant F-actin organization, aberrant phototaxis |
| DBS0237941 | abpC-/ [act15]: abpC(1-739): GFP | abpC | aberrant phototaxis |
| DBS0237949 | abpC-/ [cotB]: abpC: GFP | abpC | aberrant phototaxis |
| DBS0237948 | abpC-/ [ecmA]: abpC: GFP | abpC | wild type |
| DBS0235427 | abpD- | abpD | aberrant development, decreased cell-cell adhesion, decreased spore viability, delayed development |
| DBS0235428 | abpE- | abpE-1, abpE-2 | increased lateral pseudopod formation |
| DBS0235562 | acaA- | acaA | abolished aggregation, decreased adenylate cyclase activity |
| GP6 | acaA- | acaA | aberrant F-actin organization, aberrant cell morphology, decreased chemotaxis rate, increased lateral pseudopod formation |
| TL177 | acbA- | acbA | abolished SDF production, abolished sorting to prestalk region, decreased spore viability, increased sensitivity to cisplatin |
| DBS0235440 | acgA- | acgA | precocious spore germination |
| DBS0237788 | acgA- | acgA | decreased gene expression, decreased prespore cell differentiation |
| DBS0237790 | acgA-/ [acrA]: lacZ | acgA, acrA | mislocalized gene expression |
| DG1100 | acrA- | acrA | decreased gene expression, decreased sporulation, increased stalk length, spores inviable |
| DBS0237786 | acrA-/ [act15]: acgA(1-401) | acgA, acrA | decreased gene expression, decreased prespore cell differentiation, decreased sporulation |
| DBS0238203 | adrm1- | adrm1-1 | aberrant response to nutrients, precocious development, precocious gene expression |
| DBS0235457 | ahhA- | ahhA | aberrant culminant morphology |
| DBS0266759 | alp- | alp | wild type |
| DBS0235513 | alrA- | alrA | decreased cell motility, decreased extracellular counting factor component(s) level, decreased intracellular glucose level, increased aggregate size |
| DBS0235473 | alrA-/ [act15]: alrA | alrA | wild type |
| DBS0235474 | alxA- | alxA | aberrant fruiting body morphology, decreased growth rate, development arrests at loose aggregate stage |
| DBS0235475 | alxA- | alxA | aberrant fruiting body morphology, abolished sporulation, decreased gene expression, development arrests at mound stage |
| DBS0235488 | alxA-/ [act15]: FLAG: alxA | alxA | delayed development |
| DBS0235476 | alxA-/ [act15]: alxA(1-596): myc2 | alxA | wild type |
| DBS0235477 | alxA-/ [act15]: alxA(1-697): myc2 | alxA | wild type |
| DBS0235478 | alxA-/ [act15]: alxA(155-697): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235479 | alxA-/ [act15]: alxA(293-697): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235480 | alxA-/ [act15]: alxA(460-794): myc2 | alxA | aberrant fruiting body morphology |
| DBS0235481 | alxA-/ [act15]: alxA(D310A/ N311A) | alxA | wild type |
| DBS0235482 | alxA-/ [act15]: alxA(Q181E/ Q183) | alxA | wild type |
| DBS0235483 | alxA-/ [act15]: alxA(S700A/ S704A/ S708A) | alxA | wild type |
| DBS0235484 | alxA-/ [act15]: alxA(S700D/ S704D/ S708D) | alxA | wild type |
| DBS0235485 | alxA-/ [act15]: alxA(Y315D) | alxA | wild type |
| DBS0235486 | alxA-/ [act15]: alxA(Y315F) | alxA | wild type |
| DBS0235487 | alxA-/ [act15]: alxA: myc2 | alxA | wild type |
| DBS0235489 | alyA- | alyA | increased phagocytosis |
| DG1114 | amdA- | amdA | decreased spore viability, increased prestalk A cell differentiation, translucent sorus |
| HM1158 | amdA- | amdA | decreased fruiting body size, decreased sporulation, increased aspidocyte differentiation |
| DBS0235490 | amiB- | amiB | abolished aggregation |
| DBS0235491 | amiB- | amiB | abolished aggregation, abolished down-regulation of growth phase genes, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis to cAMP, decreased gene expression |
| DBS0235493 | ampA- | ampA | decreased prestalk cell differentiation, delayed development, delayed gene expression, delayed tip formation, increased cell-cell adhesion, increased cell-substrate adhesion, mislocalized gene expression, precocious gene expression |
| BS155 | amtA- | amtA | decreased aggregate size, decreased fruiting body size, decreased slug migration, increased growth rate |
| DBS0267100 | amtA- | amtA | decreased aggregate size, decreased extracellular ammonia level, decreased spore viability, decreased stalk length, increased intracellular ammonia level, increased intracellular glucose level, increased number of aggregates |
| DBS0267101 | amtA-/ [OE]: amtA | amtA | wild type |
| BS154 | amtC- | amtC | aberrant fruiting body morphology, aberrant protein localization, decreased gene expression, delayed culmination, development arrests at slug stage, mislocalized gene expression |
| DBS0235501 | amtC-/ [act15]: cudA | amtC, cudA | delayed culmination |
| DBS0235502 | amtC-/ [ecmA]: cudA | amtC, cudA | delayed culmination |
| DBS0235503 | amtC-/ [pspA]: cudA | amtC, cudA | development arrests at slug stage |
| DBS0235505 | apm1- | apm1 | aberrant contractile vacuole organization and biogenesis, aberrant endosome morphology, aberrant response to hypo-osmotic stress, decreased growth rate, decreased spore germination, decreased stalk width, delayed development |
| DBS0305085 | apm2-/ [dscB]: GFP: vamp7A | apm2, vamp7A | increased localization of protein to the plasma membrane |
| DBS0235507 | apm3- | apm3 | aberrant endosome morphology |
| DBS0305083 | apm3-/ [dscB]: GFP: vamp7A | apm3, vamp7A | increased localization of protein to the plasma membrane |
| DBS0235508 | apm4- | apm4 | wild type |
| DBS0235509 | aprA- | aprA | aberrant cytokinesis, aberrant fruiting body morphology, decreased spore viability, decreased sporulation, increased aggregate size, increased growth rate |
| DBS0235510 | aprA-/ actin15: : aprA | aprA | aberrant fruiting body morphology, decreased growth rate |
| DBS0238124 | aqpA- | aqpA | decreased spore viability |
| DBS0235511 | arkA- | arkA | aberrant fruiting body morphology, increased gene expression |
| DBS0235514 | aslA- | aslA-1, aslA-2 | wild type |
| DBS0236305 | atg1- | atg1 | aberrant macroautophagy, abolished autophagic vacuole formation |
| DBS0236304 | atg1- | atg1 | aberrant macroautophagy, abolished autophagic vacuole formation |
| HR131 | atg1- | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation, abolished macroautophagy, abolished sporulation, abolished stalk cell differentiation, decreased growth rate in suspension, decreased growth rate on bacterial plates, increased number of autophagosomes |
| DBS0238085 | atg1-/ [act15]: atg1 | atg1 | wild type |
| DBS0238092 | atg1-/ [act15]: atg1(1-628) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238087 | atg1-/ [act15]: atg1(K36A) | atg1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238093 | atg1-/ [act15]: atg1(P138S) | atg1 | abolished aggregation |
| HR75 | atg5- | atg5 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, abolished aggregation, abolished sporulation, multiple tips |
| HR174 | atg6- | atg6A | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, decreased fruiting body size, decreased sporulation, decreased stalk length, multiple tips |
| HR79 | atg7- | atg7 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, abolished sporulation, multiple tips |
| HR141 | atg8- | atg8 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, aberrant spore morphology, decreased fruiting body size, decreased sporulation, increased sensitivity to cisplatin, multiple tips |
| DBS0305977 | atg9- | atg9 | aberrant fruiting body morphology, aberrant slug formation, aberrant slug migration, aberrant sorus morphology, decreased growth rate, decreased phagocytosis, increased stalk width, multiple tips in mound |
| TL97 | cadA- | cadA | decreased sporulation, delayed culmination, increased prestalk cell differentiation, multiple tips |
| DBS0235568 | car4- | carD | aberrant fruiting body morphology, decreased gene expression, increased gene expression |
| DBS0235570 | carB- | carB | development arrests at mound stage |
| DBS0235573 | carmil- | carmil | decreased aggregate size, decreased basal F-actin level, decreased growth rate, decreased pinocytosis |
| IR40 | catA- | catA | abolished catalase activity |
| IR41 | catA- | catA | abolished catalase activity |
| IR29 | catA- | catA | increased sensitivity to H2O2 (peroxide) |
| DBS0235574 | catB- | catB | delayed development, spores hypersensitive to H2O2 (peroxide) |
| DBS0304455 | cblA- | cblA-1, cblA-2 | aberrant signal transduction, aberrant slug formation, abolished basal disc formation |
| HC423 | cbpA- | cbpA | decreased cell motility, delayed aggregation, increased aggregate size |
| DBS0235575 | cbpJ- | cbpJ | wild type |
| DBS0235661 | cdk8- | cdk8 | abolished aggregation, decreased gene expression, mislocalized gene expression |
| DBS0235578 | cdk8-/ [cdk8]: cdk8 | cdk8 | wild type |
| DBS0302444 | cfaD- | cfaD | aberrant fruiting body morphology, increased growth rate |
| DBS0302446 | cfaD-/ [act15]: cfaD | cfaD | wild type |
| HO101 | chcA- | chcA | aberrant cytokinesis, decreased growth rate, decreased pinocytosis |
| HO103 | chcA- | chcA | aberrant fruiting body morphology, abolished cytokinesis, abolished gene expression, abolished growth in suspension, abolished sporulation, delayed aggregation |
| DBS0235588 | chcA-/ [act15]: GFP: mhcA | chcA, mhcA | decreased positive regulation of GTPase activity |
| DBS0302455 | chcA-/ [act15]: epnA: GFP | chcA, epnA | aberrant localization of a protein to coated pits |
| DBS0235589 | chcA-/ [cotB]: lacZ | chcA | mislocalized gene expression |
| DBS0235590 | chcA-/ [ecmA]: lacZ | chcA | mislocalized gene expression |
| DBS0235591 | chcA-/ [ecmB]: lacZ | chcA | mislocalized gene expression |
| DBS0235592 | chcA-/ [pspA]: lacZ | chcA | mislocalized gene expression |
| DBS0235601 | clc- | clc | aberrant fruiting body morphology, aberrant response to hypo-osmotic stress, abolished cytokinesis, abolished growth |
| DBS0235604 | clc-/ [act15]: GFP-clc(146-194) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235605 | clc-/ [act15]: GFP-clc(85-124) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235607 | clc-/ [act15]GFP: clc(1-124) | clc | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235608 | clmA- | clmA | aberrant response to hypo-osmotic stress |
| DBS0235613 | cnrB- | cnrB | wild type |
| DBS0302655 | cnrN- | cnrN | aberrant streaming, increased F-actin polymerization, increased cAMP-induced cAMP pulse, increased number of aggregates |
| HG1770 | cnxA- | cnxA | decreased extracellular Ca2+ uptake, increased cytosolic Ca2+ response |
| DBS0235615 | cofB- | cofB | wild type |
| DBS0235616 | cofC- | cofC-1 | wild type |
| DBS0235617 | comB- | comB | abolished culmination |
| DG1016 | comB- | comB | abolished culmination |
| DBS0235618 | comC- | comC | aberrant aggregation, aberrant streaming |
| DBS0235619 | comD- | comD | abolished culmination |
| DBS0235620 | comE- | comE | aberrant fruiting body morphology, translucent sorus |
| DBS0235621 | comF- | comF-1, comF-2 | abolished aggregation |
| DBS0235622 | comG- | comG | development arrests at mound stage, multiple tips |
| DBS0235623 | comH- | comH | development arrests at mound stage |
| HG1570 | corA- | corA | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| HG1571 | corA- | corA | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| HG1569 | corA- | corA | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| DBS0305825 | corB- | corB | aberrant phagocytosis, decreased growth rate, increased cell-substrate adhesion, increased lateral pseudopod formation |
| TL55 | cotA- | cotA | aberrant spore coat morphology |
| TL52 | cotC- | cotC | aberrant spore coat morphology |
| DBS0238297 | cpnA- | cpnA | aberrant cytokinesis, aberrant fruiting body morphology, decreased culmination, decreased growth rate, delayed development, delayed response to hypo-osmotic stress |
| DBS0238320 | cpnA-/ [act15]: GFP: cpnA | cpnA | decreased culmination, delayed development, delayed response to hypo-osmotic stress |
| DBS0235627 | crlA- | crlA | decreased sorting to prestalk region, delayed tip formation, increased aggregate size, increased growth rate |
| DBS0235628 | crlA-/ [crlA]: crlA | crlA | increased aggregate size |
| DBS0235629 | crlB- | crlB | wild type |
| DBS0235630 | crlC- | crlC | wild type |
| HG1768 | crtA- | crtA | decreased extracellular Ca2+ uptake, increased cytosolic Ca2+ response |
| DBS0235633 | crtf- | crtf | abolished aggregation, abolished sporulation, decreased gene expression |
| WTC127 | cshA- | cshA | decreased growth rate, decreased phagocytosis, delayed aggregation, development arrests at loose aggregate stage |
| DBS0235624 | ctnA- | ctnA | decreased basal F-actin level, decreased cAMP-induced cAMP pulse, decreased myosin II assembly, decreased protein level, increased GTP-gamma-S-stimulated guanylyl cyclase activity, increased aggregate size, increased cAMP-induced cGMP pulse, increased cell motility, increased cell-cell adhesion, increased intracellular glucose level, increased protein level |
| DBS0235636 | ctnB- | ctnB | decreased fruiting body size, decreased gene expression, increased number of aggregates |
| DG1071 | ctr9- | ctr9 | aberrant fruiting body morphology |
| DG1058 | ctrA- | ctrA | decreased fruiting body size |
| DBS0235598 | ctxA- | ctxA | aberrant cell morphology, aberrant cytokinesis |
| HS1151 | ctxA- | ctxA | aberrant cytokinesis, decreased growth rate |
| DBS0237568 | ctxA-/ [RNAi]enlA | ctxA, enlA | wild type |
| DBS0237536 | ctxA-/ [act15]: enlA(92-497) | ctxA, enlA | wild type |
| DBS0235600 | ctxB- | ctxB | aberrant cell morphology, aberrant cytokinesis |
| DBS0235639 | cudA- | cudA | abolished sporulation, abolished stalk cell differentiation, decreased gene expression, development arrests at slug stage |
| DBS0235640 | culA- | culA | development arrests at tipped mound stage, multiple tips |
| DBS0235641 | culA-/ [cotC]: culA | culA | decreased sporulation, decreased stalk length, increased sorus size |
| DBS0235642 | culA-/ [ecmA]: culA | culA | decreased stalk length, increased sorus size |
| DBS0235643 | culA-/ [pkaC]pkaC | culA, pkaC | wild type |
| DBS0266745 | culB- | culB | aberrant slug formation, decreased fruiting body size, decreased sporulation, multiple tips in mound, precocious gene expression |
| DBS0266761 | culB-/ [act15]: pkaC | culB, pkaC | abolished aggregation, abolished gene expression, abolished sporulation, precocious gene expression |
| DBS0235651 | cybA- | cybA | aberrant development, abolished sporulation |
| AK108 | dagA- | dagA | abolished activation of adenylate cyclase, abolished aggregation, abolished gene expression, decreased gene expression |
| DBS0235652 | dagA-/ [act15]: dagA | dagA | wild type |
| DBS0235653 | darA- | darA | abolished aggregation, decreased aggregate size, decreased cell motility, decreased cell polarity |
| DBS0236307 | dcsA- | dcsA | abolished cellulose biosynthesis |
| DG1099 | dcsA- | dcsA | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk cell differentiation, abolished stalk formation |
| DG1128 | dcsA- | dcsA | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk formation |
| TL127 | dcsA- | dcsA | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk cell differentiation, abolished stalk formation |
| TL128 | dcsA-/ [act15]: dcsA | dcsA | wild type |
| DBS0235695 | dgkA- | dgkA | aberrant development, decreased chemotaxis rate, decreased spore viability, increased myosin II assembly |
| AK299 | dhkA- | dhkA | aberrant fruiting body morphology, aberrant stalk morphogenesis, decreased sporulation, increased gene expression, increased sporulation in the presence of 8-Br-cAMP, mislocalized gene expression |
| DBS0235704 | dhkB- | dhkB | precocious spore germination |
| TL135 | dhkC- | dhkC | decreased spore germination, precocious aggregation, precocious culmination, precocious development |
| DBS0235710 | dhkK- | dhkK | aberrant slug migration, delayed culmination, delayed gene expression |
| DBS0235712 | dhkK-/ [act15]: dhkK(D1125N) | dhkK | aberrant fruiting body morphology |
| DBS0235895 | dimA- | dimA | aberrant fruiting body morphology, abolished prestalk cell differentiation, decreased prestalk O cell differentiation, increased prespore cell differentiation, increased slug size, long fingers, thin fingers |
| DBS0235901 | dimB- | dimB | abolished response to DIF |
| DBS0235903 | dimB-/ [act15]: dimA: GFP | dimA, dimB | abolished localization of protein to the nucleus |
| DBS0235904 | dimB-/ [act15]: dimB: GFP | dimB | wild type |
| DBS0235902 | dimB-/ [cotB]: lacZ | dimB | increased prespore cell differentiation |
| DBS0235906 | dimB-/ [ecmAO]: lacZ | dimB | decreased prestalk O cell differentiation |
| DBS0235907 | dimB-/ [ecmO]: lacZ | dimB | aberrant prestalk cell differentiation |
| DBS0302608 | disgorgin(1-571: 581-733)/ disgorgin- | DDB_G0280955 | aberrant cellular localization, aberrant contractile vacuole organization and biogenesis |
| DBS0302597 | disgorgin- | DDB_G0280955 | aberrant contractile vacuole organization and biogenesis, aberrant response to hypo-osmotic stress |
| DBS0302607 | disgorgin-/ [OE]: lvsA | DDB_G0280955, lvsA | aberrant contractile vacuole organization and biogenesis |
| DBS0302606 | disgorgin-/ [OE]: lvsD | DDB_G0280955, lvsD | wild type |
| DBS0302678 | disgorgin-/ [OE]: rab8A | DDB_G0280955, rab8A | aberrant contractile vacuole organization and biogenesis |
| DBS0302604 | disgorgin-/ lvsA- | DDB_G0280955, lvsA | wild type |
| DBS0302605 | disgorgin-/ lvsD- | DDB_G0280955, lvsD | aberrant contractile vacuole organization and biogenesis |
| DBS0304919 | dlpA- | dlpA | aberrant cytokinesis |
| DBS0304920 | dlpB- | dlpB | aberrant cytokinesis |
| DBS0304921 | dlpC- | dlpC | aberrant cytokinesis |
| DBS0235913 | dmpA- | dmpA | aberrant fruiting body morphology, aberrant streaming, decreased sporulation, decreased stalk cell differentiation, delayed development, translucent sorus |
| HM1030 | dmtA- | dmtA | aberrant fruiting body morphology, abolished DIF production, abolished prestalk O cell differentation, decreased lower cup size, decreased outer basal disc size, decreased prestalk O cell differentiation, decreased prestalk cell differentiation, delayed development, delayed tip formation, thin fingers |
| DBS0235914 | dnapkcs- | dnapkcs | increased sensitivity to DNA-damaging agents |
| DBS0266875 | dnapkcs-/ GFP: pcna | dnapkcs, pcna | aberrant response to DNA damaging agents |
| DBS0235915 | dng1- | dng1 | decreased growth rate, delayed aggregation |
| DBS0235917 | dnmA- | dnmA | decreased cytosine methylation in genomic DNA |
| DBS0235916 | dnmA- | dnmA | aberrant culminant morphology, decreased cytosine methylation in genomic DNA, decreased sporulation, translucent sorus |
| DG2015 | docA- | docA | development arrests at mound stage |
| DBS0235920 | dokA- | dokA | aberrant response to hyperosmotic stress, decreased sporulation, translucent sorus |
| HAD172 | dpoA- | dpoA | aberrant development |
| HAD200 | dpoA- | dpoA | aberrant development |
| HAD201 | dpoA- | dpoA | aberrant development |
| HAD202 | dpoA- | dpoA | aberrant development |
| HAD203 | dpoA- | dpoA | aberrant development |
| DBS0238474 | drkC- | drkC | decreased phagocytosis, decreased phagolysosome formation |
| DBS0238511 | drkC-/ [act15]: drkC(1-497): YFP | drkC | decreased phagocytosis |
| DBS0238513 | drkC-/ [act15]: drkC(K518R): YFP | drkC | decreased phagocytosis |
| DBS0238475 | drkC-/ [act15]: drkC: YFP | drkC | wild type |
| DBS0235924 | dscA- | dscA-1, dscA-2 | aberrant cell morphology |
| DBS0235925 | dstA- | dstA | aberrant fruiting body morphology, abolished gene expression, abolished sorting to prestalk region, abolished stalk cell differentiation, decreased cell motility, decreased gene expression, delayed aggregation, increased gene expression, mislocalized gene expression |
| DBS0235926 | dstA- | dstA | aberrant fruiting body morphology, abolished sorting to prestalk region, abolished stalk cell differentiation, decreased cell motility, delayed aggregation, mislocalized gene expression |
| DBS0238237 | dstA-/ GFP: dstA(237-707): ORF+ | dstA | abolished culmination, decreased stalk length |
| DBS0238236 | dstA-/ GFP: dstA(237-707): ORF+/ [OE]dutA | dstA, dutA | wild type |
| DBS0252824 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C | 2C, dstA | aberrant fruiting body morphology |
| DBS0252823 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E | 7E, dstA, hssB | wild type |
| DBS0252826 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165 | DDB_G0276165, dstA | aberrant fruiting body morphology |
| DBS0252825 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325 | DDB_G0282325, dstA | aberrant fruiting body morphology |
| DBS0252816 | dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA | dstA, hssA | wild type |
| DBS0235928 | dstA-/ [act15]: dstA | dstA | wild type |
| DBS0235929 | dstA-/ [cprB]: dstA | dstA | wild type |
| DBS0235930 | dstA-/ [ecmAO]: dstA | dstA | wild type |
| DBS0235931 | dstB- | dstB | decreased gene expression, decreased growth rate, increased gene expression |
| DBS0235933 | dstB-/ [act15]: dstB | dstB | wild type |
| DBS0235934 | dstB-/ [act15]: dstB(L1025R) | dstB | wild type |
| DBS0235935 | dstB-/ [act15]: dstB(Y1143F) | dstB | wild type |
| DBS0235936 | dstC- | dstC | mislocalized gene expression, precocious development, precocious gene expression |
| DBS0235937 | dtfA- | dtfA | aberrant cytokinesis, aberrant fruiting body morphology, delayed tip formation |
| DBS0238234 | dutA- | dutA | wild type |
| DBS0235939 | dwwA- | dwwA | aberrant F-actin organization, aberrant cell morphology, aberrant cytokinesis |
| HJW117 | ecmA- | ecmA | long fingers, thin fingers, weak slime trail |
| HJW01 | ecmB- | ecmB | wild type |
| HJW03 | ecmB- | ecmB | wild type |
| DBS0235944 | ecmF- | ecmF | wild type |
| DBS0235946 | egeB- | egeB | development arrests at mound stage |
| DBS0302590 | elmoA- | elmoA | abolished cell polarity, decreased cell motility, decreased culmination, delayed development, increased F-actin polymerization, increased localization of protein to the pseudopodium, increased phagocytosis, increased pseudopod formation |
| DBS0302591 | elmoA-/ [act15]: elmoA: GFP | elmoA | wild type |
| DBS0302448 | epnA- | epnA | aberrant cytokinesis, aberrant protein localization, aberrant spore morphology, abolished protein phosphorylation, decreased spore viability |
| DBS0302457 | epnA-/ [act15]: GFP: epnA(253-677) | epnA | aberrant spore morphology, abolished localization of protein to coated pits, abolished localization of protein to the plasma membrane |
| DBS0302456 | epnA-/ [act15]: epnA(1-133): GFP | epnA | aberrant localization of a protein to coated pits |
| DBS0302474 | epnA-/ [act15]: epnA(R65A/ K78A): GFP | epnA | aberrant spore morphology, abolished localization of protein to coated pits, abolished localization of protein to the plasma membrane, abolished phosphatidylinositol-4, 5-bisphosphate binding |
| DBS0302475 | epnA-/ [act15]: epnA(T107A): GFP | epnA | aberrant spore morphology |
| DBS0302454 | epnA-/ [act15]: epnA: GFP | epnA | wild type |
| DBS0235947 | eppA- | eppA | decreased chemotaxis to cAMP, decreased chemotaxis to folate, decreased growth rate, decreased intracellular cAMP level, delayed development |
| DBS0235948 | eppA-/ [act6]: myc: eppA | eppA | wild type |
| HS174 | erkB- | erkB | abolished aggregation, decreased cAMP-induced cAMP pulse, decreased cell motility, decreased chemotaxis to cAMP, decreased sporulation |
| AK240 | erkB- | erkB | abolished aggregation, decreased cAMP-induced cAMP pulse, decreased sporulation |
| DBS0304864 | expl7- | expl7 | wild type |
| DBS0235951 | fadA- | fadA | increased resistance to heat shock |
| DBS0235952 | fadB- | fadB | wild type |
| DBS0236034 | fam45- | fam45 | wild type |
| DBS0236040 | fam91- | fam91 | wild type |
| DBS0235953 | fbxA- | fbxA | decreased sporulation |
| DBS0235954 | fbxA-/ [ecmA]: GFP(S65T) | fbxA | increased prespore cell differentiation |
| DBS0235956 | fbxA1- | fbxA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DBS0235957 | fbxA2- | fbxA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DBS0235958 | fbxA3- | fbxA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DG1148 | fcpA- | fcpA | aberrant fruiting body morphology |
| DBS0235960 | fcsA- | fcsA | decreased fatty acid level |
| DBS0235961 | fimA- | fimA | decreased cell size |
| DBS0235966 | forA- | forA | wild type |
| DBS0235968 | forB- | forB | wild type |
| DBS0235969 | forC- | forC | aberrant culmination, aberrant fruiting body morphology, development arrests at tipped mound stage |
| DBS0304905 | forC-/ [act15]: GFP-forC | forC | wild type |
| DBS0235970 | forH- | forH | aberrant cell morphology, aberrant pseudopod formation, decreased cell-substrate adhesion, decreased chemotaxis rate, decreased filopodium formation, increased cell motility |
| DBS0235971 | forH-/ [act15]: GFP: forH | forH | decreased cell motility, increased cell-substrate adhesion, increased filopodium formation |
| DBS0302506 | frmA- | frmA | aberrant cell morphology, decreased aggregate size, decreased cell motility, delayed aggregation, increased cell-substrate adhesion |
| DBS0304440 | frmA-/ [unk]: GFP | frmA | aberrant development, abolished phototaxis, decreased gene expression, delayed development, increased cell-cell adhesion |
| DBS0302507 | frmA-/ [unk]: frmA-HA | frmA | wild type |
| DBS0235976 | fszA- | fszA | decreased number of mitochondria, increased number of tubular mitochondria |
| DBS0235980 | fszB- | fszB | decreased growth rate, decreased number of mitochondria, increased number of tubular mitochondria |
| DG1066 | fut1- | fut1 | aberrant fruiting body morphology |
| DBS0305025 | gabT- | gabT | decreased sporulation, precocious development |
| DBS0305026 | gabT-[pkaC]: pkaC | gabT, pkaC | aberrant protein secretion |
| DG1094 | gacT- | gacT | aberrant fruiting body morphology |
| DBS0235989 | gadA- | gadA | abolished SDF production, decreased sporulation |
| TL198 | gbfA- | gbfA | abolished gene expression, development arrests at mound stage |
| DBS0305094 | gbfA- | gbfA | abolished autophagic cell death, abolished autophagic vacuole formation |
| DBS0235994 | gbpC- | gbpC | decreased fruiting body size, decreased myosin light chain kinase activation |
| DBS0235995 | gbpC- | gbpC | aberrant cell morphology, aberrant myosin II organization, decreased cell polarity, decreased chemotaxis rate, decreased fruiting body size |
| DBS0302680 | gbpC- | gbpC | abolished aggregation, decreased aggregate size |
| DBS0304912 | gbpC-/ [act15]: gbpC | gbpC | wild type |
| DBS0304917 | gbpC-/ [act15]: gbpC(1-1698: 2005-2631) | gbpC | decreased chemotaxis to cAMP |
| DBS0304918 | gbpC-/ [act15]: gbpC(311-2631) | gbpC | decreased chemotaxis to cAMP |
| DBS0304916 | gbpC-/ [act15]: gbpC(F1892A) | gbpC | decreased chemotaxis to cAMP |
| DBS0304915 | gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A) | gbpC | decreased chemotaxis to cAMP |
| DBS0304913 | gbpC-/ [act15]: gbpC(K342N) | gbpC | decreased chemotaxis to cAMP |
| DBS0304914 | gbpC-/ [act15]: gbpC(K905W) | gbpC | decreased chemotaxis to cAMP |
| DBS0235997 | gbpD- | gbpD | decreased cell-substrate adhesion, decreased lateral pseudopod formation, increased cell polarity, increased chemotaxis rate |
| DBS0235998 | gbpD-/ [act15]: gbpD | gbpD | aberrant F-actin organization, abolished aggregation, decreased chemotaxis rate, increased cell-substrate adhesion, increased lateral pseudopod formation |
| DG1120 | gbqA- | gbqA | aberrant fruiting body morphology |
| DBS0236002 | gcsA- | gcsA | abolished gene expression, cell cycle arrest, development arrests at mound stage, inviable, spores inviable |
| DBS0236003 | gcsA-/ [act15]: gcsA | gcsA | decreased spore viability, development arrests at mound stage |
| DBS0236004 | gdt1- | gdt1 | decreased growth rate in suspension, increased gene expression, precocious aggregation |
| DBS0237190 | gdt1-/ [act15]: pkaR(G135E/ G261A) | gdt1, pkaR | abolished aggregation, increased gene expression |
| DBS0236006 | gdt2- | gdt2 | increased gene expression, precocious aggregation |
| RI19 | gefA- | gefA | abolished activation of adenylate cyclase, abolished aggregation, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemoattractant-mediated F-actin polymerization, decreased chemotaxis rate |
| JB10 | gefA- | gefA | abolished aggregation |
| DBS0236009 | gefB- | gefB | aberrant cell morphology, aberrant cytoskeleton organisation, aberrant fruiting body morphology, abolished growth, abolished pinocytosis, decreased aggregate size, decreased growth rate, decreased phagocytosis, delayed aggregation, increased basal F-actin level |
| DBS0236868 | gefC- | gefC | wild type |
| DBS0236869 (DBS0235543) | gefD- | gefD | wild type |
| DBS0236870 | gefE- | gefE | aberrant phototaxis, aberrant thermotaxis |
| DBS0236011 | gefG- | gefG | wild type |
| DBS0236012 | gefK- | gefK | wild type |
| DBS0236871 | gefL- | gefL | aberrant phototaxis, aberrant thermotaxis |
| HSB61 | gefM- | gefM | aberrant activation of adenylate cyclase activity, decreased cAMP-induced cAMP pulse, decreased chemotaxis rate, decreased lateral pseudopod suppression, development arrests at mound stage, increased cAMP-induced cGMP pulse |
| DBS0304968 | gefQ- | gefQ | abolished Ras guanyl-nucleotide exchange factor activity, abolished phototaxis, abolished sorting to prestalk region, decreased fruiting body size, increased lateral pseudopod formation, increased myosin II assembly, multiple tips in mound |
| DBS0304985 | gefQ-/ [act15]: GFP: gefQ(172-654) | gefQ | abolished Ras guanyl-nucleotide exchange factor activity, decreased phototaxis |
| DBS0304986 | gefQ-/ [act15]: GFP: gefQ(910-1298) | gefQ | decreased phototaxis |
| DBS0236014 | gefR- | gefR | wild type |
| DG1109 | ggtA- | ggtA | aberrant fruiting body morphology |
| DBS0266723 | glcS-/ DH1 | glcS | aberrant stalk morphogenesis, decreased fruiting body size, decreased intracellular glycogen level, decreased spore size |
| DBS0266765 | glcS-/ HMX | glcS | aberrant cell morphology, abolished cellulose biosynthesis, decreased autophagic vacuole formation |
| DBS0236078 | glpD- | glpD | aberrant glycogen metabolism |
| DBS0236079 | gmsA- | gmsA | decreased sexual fusion |
| DBS0236080 | gmsA- | gmsA | decreased sexual fusion |
| DBS0238384 | gnt14- | gnt14 | wild type |
| DBS0238382 | gnt15- | gnt15 | abolished aggregation, abolished culmination, decreased gene expression, decreased growth rate, increased calcium-independent cell-cell adhesion |
| DBS0238383 | gnt15- | gnt15 | abolished aggregation, abolished culmination, decreased gene expression, decreased growth rate, increased calcium-independent cell-cell adhesion |
| DBS0238390 | gnt15-/ [act15]: FLAG: gnt15 | gnt15 | wild type |
| DBS0238391 | gnt15-/ [act15]: FLAG: gnt15 | gnt15 | wild type |
| DBS0236082 | gol- | gol | increased resistance to cisplatin |
| DBS0236087 | gpaA- | gpaA | decreased stalk width, increased stalk length |
| JH131 | gpaA- | gpaA | wild type |
| DBS0236091 | gpaA-/ [ecmB]: lacZ | gpaA | decreased gene expression |
| DBS0236092 | gpaA-/ [gpaA]: gpaA(G45V) | gpaA | delayed development |
| DBS0236093 | gpaA-/ [gpaA]: gpaA(Q206L) | gpaA | increased basal disc size |
| DBS0236575 | gpaB- | gpaB | decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse |
| JH104 | gpaB- | gpaB | abolished activation of adenylate cyclase, abolished aggregation, decreased gene expression |
| DBS0236096 | gpaB-/ [act15]: gpaB | gpaB | abolished aggregation |
| DBS0266942 | gpaB-/ [act15]: gpaB | gpaB | delayed aggregation |
| DBS0266939 | gpaB-/ [act15]: gpaB(1-345): gpaD(337-345) | gpaB, gpaD | abolished aggregation |
| DBS0237137 | gpaB-/ [act15]: gpaB(D154V) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237138 | gpaB-/ [act15]: gpaB(E190G) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse |
| DBS0237139 | gpaB-/ [act15]: gpaB(I104S) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237140 | gpaB-/ [act15]: gpaB(L110S) | gpaB | aberrant aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237141 | gpaB-/ [act15]: gpaB(L76P) | gpaB | abolished aggregation |
| DBS0237142 | gpaB-/ [act15]: gpaB(N74D) | gpaB | abolished aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237143 | gpaB-/ [act15]: gpaB(R64G) | gpaB | abolished aggregation, decreased chemotaxis rate |
| DBS0237144 | gpaB-/ [act15]: gpaB(S155P) | gpaB | abolished aggregation, decreased chemotaxis rate |
| DBS0236097 | gpaB-/ [gpaA]: gpaB | gpaB | abolished aggregation |
| DBS0236099 | gpaB-/ [gpaB]: gpaB | gpaB | wild type |
| DBS0236098 | gpaB-/ [gpaB]: gpaB(Q208L) | gpaB | aberrant protein localization |
| DBS0235986 | gpaC- | gpaC | aberrant activation of adenylate cyclase activity, abolished aggregation, decreased gene expression, increased protein kinase A activity |
| JH417 | gpaD- | gpaD | aberrant fruiting body morphology, abolished SDF production, decreased accumulation of cGMP, decreased chemotaxis to folate, decreased gene expression, decreased sporulation |
| DBS0266944 | gpaD-/ [act15]: gpaB | gpaB, gpaD | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| DBS0266946 | gpaD-/ [act15]: gpaB(1-345): gpaD(337-345) | gpaB, gpaD | aberrant fruiting body morphology, decreased accumulation of cGMP |
| DBS0266943 | gpaD-/ [act15]: gpaD | gpaD | wild type |
| DBS0266945 | gpaD-/ [act15]: gpaE | gpaD, gpaE | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| DBS0266947 | gpaD-/ [act15]: gpaE(1-339): gpaD(337-345) | gpaD, gpaE | aberrant fruiting body morphology, decreased accumulation of cGMP, decreased chemotaxis to folate |
| JH257 | gpaE- | gpaE | delayed gene expression, delayed tip formation |
| DBS0266941 | gpaE-/ [act15]: gpaE | gpaE | precocious tip formation |
| DBS0266948 | gpaE-/ [act15]: gpaE(1-339): gpaD(337-345) | gpaD, gpaE | precocious tip formation |
| LW1 | gpaG- | gpaG | aberrant gamma-aminobutyric acid signaling pathway, abolished SDF production, wild type |
| DBS0236107 | gpaH- | gpaH | wild type |
| DBS0236108 | gpaH- | gpaH | wild type |
| DBS0236109 | gpaI- | gpaI | decreased aggregate size, decreased fruiting body size, increased number of aggregates, precocious aggregation |
| LW5 | gpbA- | gpbA | abolished aggregation |
| LW6 | gpbA- | gpbA | aberrant protein localization, decreased CRAC localization to the plasma membrane, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis to cAMP, decreased chemotaxis to folate, decreased positive regulation of Ras GTPase activity |
| DBS0304814 | grlA- | grlA | abolished SDF production, decreased gene expression, decreased number of spores, delayed culmination, delayed gene expression |
| DBS0304815 | grlA-/ [act15]: grlA: GFP | grlA | aberrant tip formation |
| DBS0236112 | grlE- | grlE | aberrant gamma-aminobutyric acid signaling pathway, abolished SDF production, decreased sporulation |
| DBS0236113 | grlE- | grlE | aberrant gene expression, decreased chemotaxis to cAMP, delayed aggregation |
| DBS0238865 | grlJ- | grlJ | aberrant spore morphology, decreased fruiting body size, decreased spore viability, increased slug size, precocious development, precocious gene expression |
| DBS0238866 | grlJ-/ [act15]: grlJ: GFP | grlJ | wild type |
| DBS0238686 | grpA- | grpA | abolished protein secretion, decreased spore germination |
| DBS0238687 | grpA-/ [act15]: grpA-FLAG | grpA | wild type |
| ARK200 | gskA- | gskA | decreased gene expression, decreased sporulation, increased gene expression |
| DBS0236114 | gskA- | gskA | aberrant sorus morphology, decreased slug migration, decreased stalk length |
| HM338 | gskA- | gskA | aberrant fruiting body morphology, decreased prespore cell differentiation, decreased sporulation, increased prestalk cell differentiation, precocious aggregation |
| DBS0266891 | gtaC- | gtaC | aberrant prestalk B cell differentiation, aberrant streaming, abolished stalk cell differentiation in vitro, decreased aggregate size |
| DBS0236120 | gxcA- | gxcA | decreased chemoattractant-mediated F-actin polymerization, decreased positive regulation of Rac GTPase activity, delayed development |
| DBS0236121 | gxcB- | gxcB | aberrant cytoskeleton organisation, decreased exocytosis, delayed development |
| DBS0238825 | gxcDD- | gxcDD | aberrant streaming, delayed development |
| DBS0236129 | hbx2- | hbx2 | wild type |
| DBS0236130 | hbx2- | hbx2 | wild type |
| DBS0236153 | hcpA- | hcpA | decreased growth rate in suspension at low temperature |
| DBS0236157 | hcpB- | hcpB | wild type |
| DBS0305109 | hdaB- | hdaB | decreased histone deacetylase activity, decreased sporulation |
| HM1012 | helC- | helC | aberrant fruiting body morphology, decreased gene expression, delayed development |
| HM444 | helC- | helC | aberrant fruiting body morphology, decreased gene expression, delayed development |
| DG1059 | helE- | helE | increased slug migration |
| DBS0236163 | helF- | helF | delayed development, increased gene silencing by RNA interference, increased slug size, increased stalk cell differentiation |
| DBS0238583 | hipA- | hipA | aberrant spore coat morphology, aberrant spore morphology, decreased spore viability |
| DBS0252818 | hssA- | hssA | wild type |
| DBS0252699 | icmA- | icmA-1, icmA-2 | aberrant cAMP wave formation, aberrant fruiting body morphology, aberrant protein localization, aberrant signal transduction during aggregation, abolished cell polarity, abolished growth, abolished sporulation, abolished streaming, delayed gene expression, development arrests at mound stage |
| DBS0252702 | icmA-/ [act15]: TAP: YFP: rasG | icmA-1, icmA-2, rasG | abolished C-terminal protein amino acid methylation |
| DBS0252701 | icmA-/ [act15]: hICMT | icmA-1, icmA-2 | wild type |
| DBS0252700 | icmA-/ [act15]: icmA | icmA-1, icmA-2 | wild type |
| DBS0236421 | icpA- | icpA | aberrant cytokinesis, aberrant mitosis, aberrant protein localization |
| DBS0238521 | icpA-/ [act15]: GFP: icpA(1-1013) | icpA | aberrant protein localization |
| BS153 | ifkA- | ifkA | decreased extracellular counting factor component(s) level, increased aggregate size, precocious aggregation, precocious gene expression |
| BS160 | ifkB- | ifkB | increased gene expression |
| DBS0236425 | ino1- | ino1 | abolished growth, decreased intracellular myo-inositol level, decreased phagocytosis, increased intracellular 2, 3-bisphosphoglycerate level, multiple tips in mound |
| DBS0266326 | iplA- | iplA | abolished autophagic cell death, abolished autophagic vacuole formation, abolished cellulose biosynthesis |
| HM1038 | iplA- | iplA | abolished cAMP-induced Ca2+ influx, delayed aggregation, increased chemotaxis to arachidonic acid, precocious aggregation |
| DBS0252878 | iptA- | iptA | decreased spore viability |
| DBS0236031 | kctd9- | kctd9 | wild type |
| DBS0236489 | kif12- | kif12 | aberrant cytokinesis, aberrant myosin II organization, aberrant protein localization |
| DBS0236490 | kif12-/ [act15]: FLAG: kif12 | kif12 | wild type |
| DBS0302534 | kif13- | kif13 | decreased spindle stabilization, precocious spindle elongation |
| DBS0236494 | kif7- | kif7 | aberrant cell motility |
| DBS0236491 | kil1- | kil1 | abolished resistance to pathogenic bacteria |
| DBS0236492 | krsA- | krsA | decreased chemotaxis to cAMP |
| DBS0238720 | krsA- | krsA | aberrant response to hyperosmotic stress, abolished activation of adenylate cyclase, abolished streaming, decreased aggregate size, decreased cell size, decreased intracellular cAMP level, precocious culmination, precocious gene expression |
| DBS0236493 | krsA-/ [act15]: GFP: krsA | krsA | wild type |
| DBS0238721 | krsA-/ [act15]: GFP: krsA | krsA | wild type |
| DBS0238722 | krsA-/ [act15]: GFP: krsA(K49R) | krsA | aberrant streaming |
| DBS0238723 | krsA-/ [act15]: GFP: krsA(T173A) | krsA | abolished streaming |
| DBS0238725 | krsA-/ [act15]: GFP: krsA(deltaC) | krsA | aberrant streaming |
| DBS0238724 | krsA-/ [act15]: GFP: krsA(deltaKinase) | krsA | abolished streaming |
| DBS0238726 | krsA-/ [act15]: GFP: krsA(deltaNS) | krsA | abolished streaming |
| DBS0236495 | ku80- | ku80 | increased sensitivity to DNA-damaging agents |
| DBS0304820 | lagB1- | tgrB1 | decreased sporulation, delayed sporulation, development arrests at loose aggregate stage |
| AK127 | lagC- | tgrC1 | aberrant aggregation, development arrests at loose aggregate stage, increased aggregate size |
| DBS0304821 | lagC1- | tgrC1 | abolished sporulation, development arrests at loose aggregate stage in the presence of EGTA |
| DBS0236498 | lagD- | tgrD1 | aberrant aggregation, aberrant cAMP signaling during aggregation, abolished streaming |
| DBS0236499 | limB- | limB | aberrant F-actin organization, aberrant cell-cell adhesion, abolished sorting to prestalk region, decreased cell polarity, decreased cell-substrate adhesion, decreased chemotaxis rate, decreased gene expression, delayed gene expression, development arrests at mound stage |
| DBS0236502 | limB-/ [act15]: paxB: GFP | limB, paxB | development arrests at mound stage |
| DBS0236500 | limB-/ [cotC]: limB | limB | development arrests at mound stage |
| DBS0236501 | limB-/ [ecmAO]: limB | limB | wild type |
| DBS0236503 | limE- | limE | aberrant cytokinesis |
| DBS0236506 | limF- | limF | decreased phagocytosis |
| DBS0236511 | lipA- | lipA | wild type |
| DBS0236512 | lipA- | lipA | wild type |
| DG1006 | lipA- | lipA | abolished culmination |
| DG1056 | lipB- | captC | aberrant fruiting body morphology |
| DBS0236516 | lrrA- | lrrA | aberrant cell morphology, abolished aggregation, abolished chemotaxis, decreased cell polarity, decreased cell-substrate adhesion, decreased gene expression, decreased spore viability, delayed gene expression, development arrests at mound stage, increased aggregate size, increased basal F-actin level |
| DBS0236517 | lst8- | lst8 | aberrant activation of adenylate cyclase activity, abolished aggregation, decreased F-actin polymerization, decreased chemotaxis rate, decreased myosin II assembly |
| AD60 | lvsA- | lvsA | aberrant contractile vacuole organization and biogenesis, aberrant response to hypo-osmotic stress, abolished cytokinesis, decreased phagocytosis, decreased pinocytosis, increased cell-substrate adhesion |
| AD63 | lvsA- | lvsA | abolished cAMP-induced Ca2+ influx, abolished cytokinesis |
| DBS0236521 | lvsB- | lvsB | aberrant post-lysosome organization and biogenesis, increased exocytosis, increased lysosome size, increased secretion of lysosomal enzyme |
| DBS0236522 | lvsC- | lvsC | wild type |
| DBS0236523 | lvsD- | lvsD | wild type |
| DBS0236524 | lvsE- | lvsE | wild type |
| DBS0236525 | lvsF- | lvsF | wild type |
| DBS0236536 | malA- | malA | wild type |
| DBS0236543 | mekA- | mekA | decreased aggregate size, precocious development |
| DBS0266843 | mgp1- | mgp1 | aberrant contractile vacuole organization and biogenesis, abolished streaming, decreased cell motility, decreased fruiting body size, decreased stalk length, decreased stalk width, increased filopodium formation, increased phototaxis |
| DBS0266846 | mgp1-/ mgp2- | mgp1, mgp2 | aberrant contractile vacuole organization and biogenesis, aberrant culmination, decreased cell motility, decreased phototaxis, decreased stalk length, increased filopodium formation |
| DBS0266844 | mgp2- | mgp2 | increased aggregate size, increased slug size |
| HS1 | mhcA- | mhcA | aberrant protein localization |
| HS2207 | mhcA- | mhcA | abolished cytokinesis, development arrests at mound stage |
| HS2206 | mhcA- | mhcA | abolished bleb formation |
| HK323 | mhcA- | mhcA | decreased cell motility |
| DBS0266674 | mhcA-/ [act15]: GFP: abpC(9-148) | abpC, mhcA | decreased pseudopod retraction, decreased uropod retraction |
| DBS0237564 | mhcA-/ [act15]: GFP: ctxA/ [RNAi]enlA | ctxA, enlA, mhcA | aberrant cytokinesis, contractile ring contraction |
| DBS0266675 | mhcA-/ [act15]: GFP: mhcA(E476K) | mhcA | decreased pseudopod retraction |
| DBS0236548 | mhcA-/ [act15]: GFP: pats1(2087-2351) | mhcA, pats1 | aberrant cytokinesis |
| DBS0236549 | mhcA-/ [act15]: limE(1-145): GFP | limE, mhcA | increased F-actin polymerization |
| DBS0238158 | mhcA-/ [act15]: mhcA(81-2116) | mhcA | decreased growth rate, development arrests at tipped mound stage |
| CW0401 | mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A) | mhcA | decreased growth rate in suspension, increased myosin II assembly |
| DBS0236550 | mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A) | mhcA | decreased filopodium formation |
| DBS0236551 | mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D) | mhcA | increased filopodium formation |
| DBS0238399 | mhcA-/ [act15]: rapA(G12V) | mhcA, rapA | aberrant myosin II organization, increased basal F-actin level, increased cell polarity |
| DBS0236552 | mhcA-/ [mhcA]: mhcA(1-1224) | mhcA | aberrant cytokinesis, development arrests at mound stage |
| DBS0238157 | mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H) | mhcA | decreased actin filament sliding |
| DBS0236547 | mhcA-/ [unk]: GFP: icpA | icpA, mhcA | aberrant protein localization |
| CW0371 | mhkA- | mhkA | increased myosin II assembly |
| DBS0236557 | mhkA-/ [act15]: mhkA | mhkA | aberrant cytokinesis, decreased growth rate in suspension, decreased myosin II assembly, development arrests at mound stage |
| CW0166 | mhkB- | mhkB | increased myosin II assembly |
| CW0403 | mhkC- | mhkC | aberrant cytokinesis, increased myosin II assembly |
| DG1069 | mhkC- | mhkC | aberrant fruiting body morphology |
| CW0435 | mhkD- | mhkD | increased myosin II assembly |
| DBS0236559 | midA- | midA | aberrant spore morphology, decreased cell size, decreased growth rate in suspension, decreased growth rate on bacterial plates, decreased intracellular glycogen level, increased extracellular ammonia level, increased intracellular glutamate level, increased slug migration |
| DG1020 | migA- | migA | aberrant fruiting body morphology, abolished slug migration, decreased fruiting body size |
| DBS0236560 | mkcA- | mkcA | decreased gene expression |
| DG1101 | mkcB- | mkcB | decreased fruiting body size |
| DBS0236564 | mkkA- | mkkA | decreased sorus size, increased stalk length, precocious culmination |
| DG1121 | mkpA- | mkpA | abolished aggregation |
| DBS0236566 | mlcE- | mlcE | aberrant cytokinesis, aberrant development, decreased cell motility, decreased growth rate in suspension, delayed aggregation, mislocalized gene expression |
| DBS0238058 | mlcE-/ [act15]: myc: mlcE | mlcE | wild type |
| DBS0236567 | mlcR- | mlcR | aberrant cytokinesis, aberrant myosin II organization, development arrests at mound stage |
| HS183 | mlkA- | mlkA | aberrant cytokinesis |
| DG1033 | modA- | modA | aberrant fruiting body morphology |
| DBS0266903 | mpl1- | mpl1 | abolished aggregation, abolished streaming, decreased cell motility, decreased chemotaxis to cAMP |
| DBS0266904 | mpl1-/ [act15]: flag: mpl1 | mpl1 | wild type |
| DBS0236569 | mrps4- | mrps4 | aberrant fruiting body morphology, delayed aggregation |
| DBS0236570 | mybB- | mybB | abolished aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased gene expression |
| DBS0236571 | mybB- | mybB | abolished aggregation |
| HM388 | mybC- | mybC | abolished culmination, decreased SDF production, decreased gene expression |
| DBS0236572 | mybE- | mybE | abolished outer basal disc formation, increased slug size |
| DBS0237709 | mybE-/ [mrrA]: lacZ | mrrA, mybE | aberrant prestalk cell differentiation |
| DBS0236573 | mybE-/ mybE: GFP | mybE | aberrant prestalk cell differentiation, wild type |
| HDT1 | myoA- | myoA | decreased cell motility, decreased chemotaxis rate, decreased lateral pseudopod suppression, delayed aggregation |
| HDT2 | myoA- | myoA | increased secretion of lysosomal enzyme |
| DBS0236579 | myoB- | myoB | increased secretion of lysosomal enzyme |
| DBS0236580 | myoB- | myoB | decreased cell motility, decreased lateral pseudopod suppression, decreased phagocytosis, delayed aggregation |
| DBS0236583 | myoB-/ [AS]myoD | myoB, myoD | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis |
| DBS0236584 | myoB-/ [AS]myoD/ [KD]myoC | myoB, myoC, myoD | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis, increased number of pinosomes, small pinosomes |
| DBS0236585 | myoC- | myoC | decreased phagocytosis |
| DBS0236587 | myoD- | myoD | wild type |
| HDT8 | myoF- | myoF | wild type |
| DBS0236589 | myoI- | myoI | decreased spore germination |
| DBS0236592 | myoI- | myoI | aberrant cell morphology, aberrant cytokinesis, decreased cell-substrate adhesion, decreased phagocytosis |
| HDT15 | myoI- | myoI | decreased phagocytosis |
| HDT17 | myoI- | myoI | decreased cell-cell adhesion, decreased cell-substrate adhesion, decreased filopodium formation, decreased phagocytosis, decreased protein level |
| DBS0266889 | myoI-/ [act15]: GFP: myoI | myoI | wild type |
| DBS0266890 | myoI-/ [act15]: GFP: myoI(809-1154) | myoI | decreased phagocytosis |
| DBS0237617 | myoI-/ [act15]: gbpD | gbpD, myoI | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| HTD7 | myoJ- | myoJ | wild type |
| DBS0236595 | myoM- | myoM | wild type |
| SB12 | napA- | napA | decreased basal F-actin level, decreased cell motility, decreased cell polarity, decreased cell size, decreased cell-cell adhesion, decreased cell-substrate adhesion, decreased phototaxis |
| HC476 | ncsA- | ncsA | increased intracellular cAMP level, precocious development, precocious gene expression |
| HC477 | ncsA- | ncsA | increased intracellular cAMP level, precocious development, precocious gene expression |
| DBS0304633 | nfaA- | nfaA | aberrant cAMP signaling during aggregation, aberrant localization of protein to the plasma membrane, aberrant regulation of Ras GTPase activity, aberrant regulation of protein kinase activity, decreased cell motility, decreased chemotaxis to cAMP, delayed aggregation, increased basal F-actin level, increased chemoattractant-mediated F-actin polymerization, increased pseudopod formation |
| DBS0236604 | nhe1- | nhe1 | aberrant F-actin organization, decreased cell polarity, decreased chemotaxis rate, decreased intracellular pH level |
| DBS0236605 | nhe1-/ [act15]: nhe1: HA | nhe1 | wild type |
| DBS0236606 | nosA null (15-S-12) | nosA | development arrests at mound stage |
| DBS0236607 | nosA null (2E4) | nosA | development arrests at mound stage |
| DBS0235950 | nosA- | nosA | development arrests at mound stage |
| DBS0236608 | noxA- | noxA | aberrant development, abolished sporulation |
| DBS0236611 | noxA-/ [act15]: noxA: myc2 | noxA | aberrant fruiting body morphology |
| DBS0236612 | noxB- | noxB | aberrant development, abolished sporulation, decreased superoxide production |
| DBS0236613 | noxC- | noxC | aberrant development, abolished sporulation |
| DBS0238849 | npcA- | npcA | wild type |
| DBS0236695 | nramp1- | nramp1 | abolished iron ion transport, increased infection rate by Legionella pneumophila, increased infection rate by Mycobacterium avium |
| DBS0236696 | nramp1-/ [act15]: nramp1: GFP | nramp1 | decreased infection rate by Legionella pneumophila |
| DBS0236697 | nramp1-/ [act15]: nramp1: GFP | nramp1 | decreased infection rate by Legionella pneumophila |
| DBS0236955 | nxnA- | nxnA | decreased chemotaxis to cAMP, decreased culmination, decreased growth rate, decreased lysosomal enzyme activity, delayed development |
| DBS0236702 | nxnA-/ [act15]: GFP: nxnB | nxnA, nxnB | development arrests at mound stage |
| DBS0236704 | osbA- | osbA | increased slug migration, precocious development |
| DBS0238357 | p2xA- | p2xA | aberrant response to hypo-osmotic stress |
| DBS0238362 | p2xA-/ [act15]: p2xA: GFP | p2xA | wild type |
| DBS0236705 | pakA- | pakA | aberrant cytokinesis, delayed development |
| DBS0236706 | pakA- | pakA | wild type |
| DBS0236707 | pakA-/ [act15]: pakA | pakA | wild type |
| DBS0236709 | pakB- | pakB | decreased growth rate |
| DBS0236710 | pakB-/ [act15]: GFP-pak(1-337): (563-851) | pakB | abolished cytokinesis, increased phagocytosis, increased pinocytosis |
| DBS0236712 | pakB-/ [act15]: GFP-pak(1-~600) | pakB | abolished cytokinesis |
| HC392 | patB- | patB | abolished growth in acidic medium, abolished growth on bacterial plates |
| DBS0236726 | pats1- | pats1 | aberrant cytokinesis |
| DBS0236727 | pats1-/ [act15]: GFP: pats1(2087-2351) | pats1 | aberrant cytokinesis |
| DBS0236728 | paxB- | paxB | aberrant fruiting body morphology, abolished slug migration, decreased cell-substrate adhesion, decreased gene expression, decreased sorting to prestalk region, development arrests at mound stage |
| DBS0304926 | paxB- | paxB | aberrant cell separation during cytokinesis, aberrant cytokinesis, decreased cell motility, decreased cell-substrate adhesion |
| DBS0304930 | paxB-/ [act15]: GFP: paxB | paxB | wild type |
| DBS0236730 | paxB-/ [ecmA]: paxB: GFP | paxB | decreased sorting to prestalk region |
| DBS0236732 | paxB-/ [pspA]: paxB: GFP | paxB | decreased sorting to prestalk region |
| DBS0236733 | pcp- | pcp | wild type |
| DBS0236734 | pde4- | pde4 | decreased culmination, delayed culmination, delayed slug formation |
| DBS0236735 | pde4-/ [act15]: pde4: GFP | pde4 | wild type |
| DBS0236736 | pdeD- | pdeD | decreased Ca2+-induced Ca2+ influx, decreased cAMP-induced Ca2+ influx, delayed cAMP-induced Ca2+ influx |
| UK7 | pdsA- | pdsA | abolished aggregation, decreased 3', 5'-cyclic-AMP phosphodiesterase activity |
| DBS0236741 | pefA- | pefA | wild type |
| DBS0236744 | pefB- | pefB | wild type |
| HW260 | pgtA- | pgtA | increased cell size |
| DBS0236752 | phdA- | phdA | decreased aggregate size, decreased basal F-actin level, decreased chemotaxis rate, decreased fruiting body size |
| DBS0236753 | phdA-/ [act15]: phdA | phdA | wild type |
| DBS0236754 | phdA-/ [act15]: phdA: GFP | phdA | wild type |
| DBS0304869 | phg1A-/ [act15]: phg1a(1-276): phg1b(221-587) | phg1a, phg1b | decreased phagocytosis |
| DBS0304868 | phg1A-/ [act15]: phg1b | phg1a, phg1b | decreased cell-substrate adhesion, decreased phagocytosis, increased secretion of lysosomal enzyme |
| DBS0304870 | phg1A-/ [act15]: phg1b(1-220): phg1a(277-642) | phg1a, phg1b | decreased phagocytosis |
| DBS0236755 | phg1a- | phg1a | aberrant cytokinesis, abolished resistance to pathogenic bacteria, decreased cell-substrate adhesion, decreased growth rate, decreased phagocytosis, development arrests at slug stage, increased secretion of lysosomal enzyme |
| DBS0236757 | phg1a-/ [act15]: kil1 | kil1, phg1a | wild type |
| DBS0304866 | phg1b- | phg1b | abolished culmination, decreased growth rate, decreased phagocytosis, increased secretion of lysosomal enzyme |
| DBS0236758 | phg2- | phg2 | aberrant F-actin organization, aberrant cell morphology, aberrant cytokinesis, aberrant response to nutrients, decreased cell motility, decreased cell-substrate adhesion, decreased phagocytosis, precocious development, precocious gene expression |
| DBS0238400 | phg2- | phg2 | aberrant cell morphology, decreased chemotaxis to cAMP, increased basal F-actin level, increased cell-substrate adhesion, increased filopodium formation, increased phagocytosis |
| DBS0236760 | phg2-/ [act15]: GFP: phg2(199-1389) | phg2 | decreased phagocytosis |
| DBS0237615 | phg2-/ [act15]: gbpD | gbpD, phg2 | aberrant cell morphology, abolished chemotaxis to cAMP, increased pseudopod formation |
| HG1648 | phgA- | phgA | aberrant contractile vacuole organization and biogenesis, aberrant response to hypo-osmotic stress |
| DBS0236761 | phgA-/ [act6]: GFP: lvsA | lvsA, phgA | aberrant protein localization |
| DBS0236762 | phlp1- | phlp1 | aberrant protein localization, aberrant regulation of protein modification, abolished aggregation, abolished chemotaxis, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased growth rate in suspension, decreased growth rate on bacterial plates |
| DBS0236763 | phlp1-/ [OE]: phpl1 | phlp1 | wild type |
| DBS0236764 | phlp3- | phlp3 | wild type |
| HW288 | phyA- | phyA | abolished culmination, abolished sporulation, abolished stalk formation, decreased peptidyl-proline hydroxylation |
| DBS0266771 | phyA-/ [ecmA]: phyA(D132N): myc | phyA | decreased peptidyl-proline hydroxylation |
| DBS0266770 | phyA-/ [ecmA]: phyA(R276A): myc | phyA | abolished culmination, abolished peptidyl-proline hydroxylation |
| DBS0236767 | pia- | piaA | aberrant activation of adenylate cyclase activity |
| DBS0236770 | piaA- | piaA | aberrant cytokinesis |
| DBS0236771 | piaA- | piaA | abolished aggregation, decreased myosin II assembly |
| DBS0304637 | piaA- | piaA | aberrant protein tyrosine phosphorylation, decreased cell motility, decreased cell polarity, decreased chemotaxis rate |
| DBS0236772 | pikA- | pikA | wild type |
| DBS0236774 | pikB- | pikB | wild type |
| DBS0236776 | pikC- | pikC | wild type |
| DBS0236777 | pikD1| pikD | aberrant fruiting body morphology, abolished slug migration, decreased aggregate size, decreased number of spores, delayed aggregation | |
| DBS0236778 | pikE- | pikE | wild type |
| SB16 | pirA- | pirA | decreased cell size, increased cell motility |
| SB3 | pirA- | pirA | decreased cell motility, increased basal F-actin level, increased cell size, increased pseudopod formation |
| DBS0235411 | pkaR- | pkaR | aberrant response to lithium, aberrant response to valproic acid, decreased fruiting body size |
| DBS0236786 | pkgB- | pkgB | abolished SDF production, development arrests at mound stage |
| DBS0304638 | pkgB- | pkgB | decreased cell-substrate adhesion, decreased chemotaxis rate, increased cell motility |
| DBS0236787 | pkgB-/ [act15]: pkbA | pkbA, pkgB | wild type |
| DBS0236789 | pkgB-/ [act15]: pkgB(K182M) | pkgB | development arrests at mound stage |
| DBS0236790 | pkgB-/ [gbfA]: pkbA | pkbA, pkgB | wild type |
| DBS0236791 | pkgB-/ [gbfA]: pkgB | pkgB | wild type |
| DBS0238068 | plaA- | plaA | abolished aggregation |
| DBS0238067 | plaA- | plaA | abolished aggregation |
| DG1067 | plbG- | plbG | decreased stalk length, decreased stalk width |
| HAD236 | plc- | plc | aberrant chemotaxis to cAMP, abolished aggregation, decreased CRAC localization to the plasma membrane, decreased activation of protein kinase B, decreased localization of protein to the cytoplasm |
| HD1.19 | plc- | plc | aberrant negative chemotaxis |
| HD10 | plc- | plc | wild type |
| DBS0267125 | plc-/ [OE]: dagA(PH): GFP/ [OE]: plc | dagA, plc | aberrant protein localization, decreased chemotaxis to cAMP, increased CRAC localization to the plasma membrane |
| DBS0236796 | pldB- | pldB | precocious aggregation |
| DBS0236797 | pldB-/ [act15]: pldB: GFP | pldB | abolished aggregation |
| DBS0236799 | plip- | plip | delayed aggregation |
| DBS0236820 | ponA- | ponA | aberrant development, decreased actin nucleation on plasma membranes, decreased lateral pseudopod traction, precocious aggregation |
| DBS0236821 | ponA- | ponA | aberrant development, decreased actin nucleation on plasma membranes, decreased lateral pseudopod traction, precocious aggregation |
| DG1057 | potA- | potA | aberrant fruiting body morphology |
| DBS0236824 | ppk1- | ppk1 | decreased fruiting body size, decreased growth rate on bacterial plates, decreased phagocytosis, decreased sporulation, delayed culmination |
| DBS0236825 | ppk1-/ [act15]: ppk1 | ppk1 | wild type |
| DBS0238099 | ppp4C- | ppp4c | delayed development, development arrests at mound stage |
| DBS0238110 | ppp4C-/ [act15]: smkA | ppp4c, smkA | delayed development, development arrests at mound stage |
| DBS0238033 | proC- | proC | decreased cell polarity, decreased chemotaxis rate, increased lateral pseudopod formation |
| DBS0238034 | proC-/ [unk]: FLAG: proC | proC | wild type |
| DBS0266716 | pscA- | pscA | wild type |
| HOK2 | psiA- | psiA | abolished prespore cell division |
| DBS0236021 | psiM- | psiM | wild type |
| DBS0236022 | psiM- | psiM | wild type |
| DBS0236828 | pslA- | pslA | abolished gene expression, abolished sporulation, abolished stalk cell differentiation in vitro, decreased sorus size, increased aggregate size, increased stalk length, mislocalized gene expression |
| DBS0236829 | psmC1- | psmC1 | abolished slug migration, curly fingers, increased cell size, resistant to spectinomycin |
| DBS0302352 | psrA- | psrA | decreased culmination, delayed development, delayed gene expression, increased protein kinase activation, increased protein phosphorylation |
| DBS0302356 | psrA-/ [act15]: FLAG: gskA | gskA, psrA | increased protein kinase activation |
| DBS0302353 | psrA-/ [act15]: ecmA: lacZ | psrA | aberrant gene expression |
| DBS0302354 | psrA-/ [act15]: ecmB: lacZ | psrA | aberrant gene expression |
| DBS0302357 | psrA-/ [act15]: gskA(K84M/ K85M) | gskA, psrA | decreased culmination, decreased gene expression, delayed development |
| DBS0302355 | psrA-/ [act15]: psrA | psrA | wild type |
| HM1289 | pten- | pten | decreased cell motility |
| DBS0236830 | pten- | pten | abolished CRAC localization to the plasma membrane, decreased F-actin polymerization, decreased cell motility, decreased chemotaxis to cAMP, decreased lateral pseudopod suppression, increased lateral pseudopod formation |
| DBS0236832 | ptpA1- | ptpA1-1 | decreased prespore cell differentiation, increased prestalk O cell differentiation, precocious development |
| DBS0236833 | ptpB- | ptpB | increased slug size |
| DBS0236835 | pufA- | pufA | aberrant fruiting body morphology, precocious development |
| DBS0304391 | pyk3- | pyk3 | decreased gene expression, delayed culmination, increased gene expression, increased prespore cell differentiation |
| DBS0304393 | pyk3-/ [act15]: T7: pyk3 | pyk3 | wild type |
| DBS0236837 | pyr56- | pyr56 | resistant to 5-fluoroorotic acid (5-FOA), uracil auxotroph |
| DBS0236838 | pyr56- | pyr56 | resistant to 5-fluoroorotic acid (5-FOA), uracil auxotroph |
| DBS0236839 | qkgA- | qkgA-1, qkgA-2 | delayed aggregation, increased aggregate size, increased growth rate |
| DBS0236841 | racB- | racB | aberrant fruiting body morphology, decreased basal F-actin level, decreased chemoattractant-mediated F-actin polymerization, decreased chemotaxis rate, decreased myosin II assembly, delayed aggregation |
| DBS0236842 | racC- | racC | aberrant cell morphology, aberrant protein localization, decreased chemotaxis rate |
| DBS0237191 | racC-/ [act15]: CFP: racC | racC | increased chemoattractant-mediated F-actin polymerization |
| DBS0236843 | racF2- | racF2 | decreased sexual fusion, increased aggregate size, increased cell-cell adhesion |
| DBS0236849 | racG- | racG | decreased cell motility |
| DBS0236850 | racH- | racH | aberrant protein localization, decreased exocytosis |
| DBS0266936 | rapgap1- | rapgap1 | decreased cell motility, decreased myosin II assembly, decreased positive regulation of Rap GTPase activity, increased basal F-actin level, increased cell-substrate adhesion |
| DBS0266937 | rapgap1-/ [act15]: GFP: rapgap1 | rapgap1 | decreased cell-substrate adhesion, increased basal F-actin level, increased cell motility, increased lateral pseudopod formation, increased myosin II assembly, increased positive regulation of Rap GTPase activity |
| DBS0236852 | rasB- | rasB | decreased growth rate |
| DBS0236853 | rasC-/ AX2 | rasC | abolished aggregation, decreased activation of protein kinase B, decreased cell motility |
| DBS0236854 | rasC-/ JH10 | rasC | aberrant gene expression, abolished chemotaxis to cAMP, decreased activation of protein kinase B |
| DBS0237614 | rasC-/ [act15]: gbpD | gbpD, rasC | aberrant cell morphology, increased cell-substrate adhesion |
| DBS0236860 | rasD- | rasD | aberrant phototaxis, aberrant thermotaxis |
| DBS0236862 | rasG-/ AX2 | rasG | decreased activation of protein kinase B, decreased cAMP-induced cGMP pulse, decreased gene expression, delayed aggregation, delayed gene expression |
| IR15 | rasG-/ AX2 | rasG | decreased growth rate, increased cell size |
| IR17 | rasG-/ AX3 | rasG | aberrant cytokinesis, decreased cell motility, increased cell size |
| DBS0236863 | rasG-/ JH10 | rasG | abolished activation of Rap GTPase activity, decreased activation of protein kinase B, decreased cAMP-induced cGMP pulse, decreased gene expression, delayed aggregation, delayed gene expression |
| DBS0236864 | rasG-/ [rasG]: rasB | rasB, rasG | decreased growth rate in suspension |
| DBS0236872 | rasS- | rasS | decreased cell polarity |
| DBS0236873 | rasS- | rasS | aberrant cytoskeleton organisation, abolished growth in suspension, decreased growth rate in liquid medium on solid sufaces, decreased rate of endocytosis, increased basal F-actin level, increased cell motility |
| DBS0236874 | rasZ- | rasZ | wild type |
| DBS0236877 | rblA- | rblA | decreased cell size, increased prestalk cell differentiation in response to DIF-1, increased sorting to prestalk region, precocious development |
| DBS0236878 | rbrA- | rbrA | decreased gene expression, decreased phototaxis, decreased sorting to prestalk region, decreased sporulation, development arrests at slug stage, increased gene expression, mislocalized gene expression |
| DBS0236879 | rbrA-/ [unk]: rbrA | rbrA | wild type |
| DBS0236880 | rckA- | rckA | delayed gene expression, delayed slug formation, increased aggregate size, increased chemotaxis rate, precocious aggregation |
| DBS0236885 | rckA-/ [act15]: myc: rckA | rckA | decreased chemotaxis rate, delayed development |
| DBS0236881 | rckA-/ [act15]: myc: rckA(C551A) | rckA | decreased chemotaxis rate, delayed slug formation |
| DBS0236882 | rckA-/ [act15]: myc: rckA(E510G) | rckA | decreased chemotaxis rate, wild type |
| DBS0236883 | rckA-/ [act15]: myc: rckA(E510G/ N511A) | rckA | decreased chemotaxis rate, delayed slug formation |
| DBS0236884 | rckA-/ [act15]: myc: rckA(K867A) | rckA | decreased chemotaxis rate, development arrests at mound stage |
| FR17 | rdeA- | rdeA | aberrant fruiting body morphology, decreased aggregate size, precocious aggregation, precocious development, precocious gene expression |
| FR17 | rdeA- | rdeA | aberrant fruiting body morphology, decreased aggregate size, precocious aggregation, precocious development, precocious gene expression |
| DBS0236886 | rdeA-/ [act15]: rdeA | rdeA | wild type |
| DBS0236887 | recA- | recA | increased sensitivity to H2O2 (peroxide), increased sensitivity to UV light, increased sensitivity to mitomycin C (MMC) |
| DBS0266664 | redA- | redA | aberrant mound color, development arrests at mound stage |
| DG1047 | redA- | redA | aberrant mound color, development arrests at mound stage |
| DBS0236889 | regA- | regA | aberrant fruiting body morphology, increased resistance to cisplatin |
| HM332 | regA- | regA | decreased lateral pseudopod suppression |
| HR45 | regA- | regA | aberrant fruiting body morphology |
| DBS0235706 | regA-/ [act15]: dhkK(D1125N) | dhkK, regA | aberrant fruiting body morphology, precocious development |
| DBS0235708 | regA-/ [act15]: dhkK(H825Q) | dhkK, regA | aberrant fruiting body morphology, precocious development |
| DBS0236893 | rgaA- | rgaA | aberrant cytokinesis, abolished culmination, abolished sorting to prestalk region, abolished stalk cell differentiation, decreased sporulation |
| DBS0236894 | rhgA- | rhgA | wild type |
| DBS0236902 | ripA-/ [unk]: ripA(K680E/ R681E) | ripA | aberrant development, decreased chemotaxis rate |
| DBS0236901 | ripA-/ [unk]ripA | ripA | wild type |
| DBS0236903 | rnpA- | rnpA | increased gene expression |
| DBS0238225 | rpkA- | rpkA | aberrant response to conditioned medium factor, abolished aggregation, decreased cell motility, decreased cell polarity, development arrests at loose aggregate stage |
| DBS0236875 | rtoA- | rtoA | decreased infection rate by Legionella pneumophila, decreased rate of endocytosis, delayed culmination, increased prestalk cell differentiation |
| DBS0236911 | rtoA- | rtoA | delayed development |
| DBS0236914 | rzpA- | rzpA | aberrant aggregation, decreased gene expression, decreased slug migration, delayed development, increased aggregate size, increased gene expression |
| DBS0236921 | sadA- | sadA | aberrant F-actin organization, aberrant cell morphology, aberrant cytokinesis, abolished cell-substrate adhesion, decreased phagocytosis, increased growth rate |
| DBS0236922 | sadA-/ [act15]: sadA: GFP | sadA | wild type |
| DBS0236924 | scrA- | scrA | decreased basal F-actin level, decreased cell size, decreased fruiting body size, increased lateral pseudopod formation, multiple tips, precocious development |
| IR46 | scrA- | scrA | decreased cell motility, decreased cell size |
| IR48 | scrA- | scrA | aberrant cytokinesis, decreased growth rate |
| DBS0236925 | scrA- | scrA | increased filopodium formation |
| DBS0237774 | scrA-/ [unk]: scrA(97-443): GFP | scrA | aberrant cytokinesis, aberrant cytoskeleton organisation, decreased chemotaxis to cAMP, increased cell size |
| DBS0237779 | scrA-/ [unk]: scrA: GFP | scrA | wild type |
| DBS0236928 | set1- | set1 | abolished histone H3-K4 methylation, precocious aggregation, precocious gene expression |
| DG1008 | sfbA- | sfbA | decreased fruiting body size |
| SA576 | sgkA- (sgkAΔ) | sgkA | decreased growth rate, increased sensitivity to carboplatin, increased sensitivity to cisplatin |
| HM1091 | sgkB- | sgkB | decreased growth rate, increased sensitivity to carboplatin, increased sensitivity to cisplatin |
| SA555 | sglA- | sglA | aberrant cytoskeleton organisation, abolished slug migration, decreased cell motility, decreased chemotaxis rate, decreased fruiting body size, decreased gene expression, decreased lateral pseudopod suppression, decreased sporulation, increased aggregate size, increased resistance to cisplatin, increased stalk width |
| SA554 | sglA- | sglA | decreased aggregate size, delayed aggregation |
| DBS0236934 | shkA- | shkA | aberrant F-actin organization, aberrant aggregation, aberrant cytokinesis, decreased cell polarity, decreased chemotaxis rate, decreased fruiting body size, decreased phagocytosis |
| DBS0236935 | sibA- | sibA | decreased cell-substrate adhesion, decreased phagocytosis |
| DBS0302653 | sibC- | sibC | decreased phagocytosis |
| DBS0236936 | sigB- | sigB | wild type |
| DBS0236937 | sigD- | sigD | wild type |
| DBS0236938 | smkA- | smkA | aberrant cytokinesis, decreased chemotaxis rate, decreased myosin II assembly, delayed development |
| HDB7YA | smlA- | smlA | decreased GTP-gamma-S-stimulated guanylyl cyclase activity, decreased cAMP-induced cGMP pulse, decreased cell-cell adhesion, decreased fruiting body size, decreased protein level, decreased secretion of lysosomal enzyme, increased basal F-actin level, increased cAMP-induced cAMP pulse, increased cell motility, increased extracellular counting factor component(s) level, increased intracellular counting factor component(s) level, increased myosin II assembly, increased protein level, increased resistance to cisplatin |
| DBS0304496 | smlA-/ sslA1(CR11) | smlA, sslA1 | increased fruiting body size |
| DBS0302523 | sodC- | sodC | aberrant cytokinesis |
| DBS0302524 | sodC- | sodC | aberrant aggregation, aberrant cell morphology, aberrant localization of protein to the plasma membrane, decreased chemoattractant-mediated F-actin polymerization, decreased chemotaxis rate, decreased positive regulation of Ras GTPase activity, increased basal F-actin level, increased localization of protein to the plasma membrane |
| HL351 | spiA- | spiA | decreased spore viability |
| DBS0236945 | splA- | splA | aberrant spore morphology, decreased stalk length, increased sorus size, spores inviable, translucent sorus |
| DBS0236947 | spnA- | spnA | aberrant development, abolished prespore cell differentiation, abolished prestalk cell differentiation, development arrests at mound stage |
| DBS0236949 | sr- | sr | decreased cytochrome C oxidase activity, decreased growth rate, decreased intracellular pteridine level, decreased spore viability |
| DBS0236950 | srfA(1-8): lacZ | srfA | aberrant fruiting body morphology, decreased slug migration, delayed culmination |
| DBS0236951 | srfA- | srfA | aberrant spore coat morphology, aberrant spore morphology, decreased gene expression, decreased spore viability |
| DBS0266691 | srfB- | srfB | aberrant cAMP signaling, aberrant cytokinesis, abolished streaming, decreased growth rate, increased lateral pseudopod formation, increased pinocytosis, precocious aggregation, precocious gene expression |
| DBS0304409 | srsA- | srsA | decreased gene expression, delayed aggregation, increased aggregate size, increased gene expression |
| DBS0236952 | stkA- | stkA | aberrant fruiting body morphology, decreased gene expression, delayed gene expression, increased gene expression, increased prestalk cell differentiation |
| HM1157 | stlA- | stlA | wild type |
| HM1154 | stlB- | stlB | aberrant fruiting body morphology, abolished DIF production, abolished lower cup formation, abolished outer basal disc formation, abolished prestalk B cell differentation, decreased prestalk O cell differentiation, decreased prestalk cell differentiation |
| DBS0304547 | svkA- | svkA | aberrant cytokinesis, aberrant fruiting body morphology, delayed cell separation during cytokinesis |
| DBS0236958 | t96A | regA | decreased spore germination, precocious sporulation |
| AK1200 | tagA- | tagA | aberrant fruiting body morphology, abolished SDF production |
| AK859 | tagA- | tagA | abolished SDF production, decreased spore viability, increased prestalk A cell differentiation, multiple tips in mound |
| AK1201 | tagA-/ [ecmA]: GFP | tagA | abolished sorting to prestalk region |
| AK228 | tagB- | tagB | aberrant prestalk A cell differentiation, abolished DIF production, development arrests at mound stage |
| DBS0236975 | tagC- | tagC | development arrests at mound stage, spores inviable |
| DBS0236976 | talA- | talA | aberrant cell morphology, aberrant cytokinesis, decreased cell-substrate adhesion, decreased phagocytosis |
| HG1666 | talA- | talA | aberrant cytokinesis, decreased cell-cell adhesion, decreased cell-substrate adhesion, decreased growth rate, decreased phagocytosis |
| HG1663 | talA- | talA | decreased cell-substrate adhesion |
| HG1664 | talA- | talA | decreased growth rate, decreased phagocytosis |
| HG1665 | talA- | talA | aberrant cytokinesis, decreased cell-cell adhesion |
| DBS0304585 | talA-/ [act15]: FLAG: talB | talA, talB | decreased cell-substrate adhesion |
| DBS0237616 | talA-/ [act15]: gbpD | gbpD, talA | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| DBS0238395 | talA-/ [act15]: rapA(G12V) | rapA, talA | increased cell-substrate adhesion |
| DBS0304582 | talA-/ talB-/ [act15]: FLAG: talB | talA, talB | wild type |
| HKT104 | talB- | talB | decreased cell motility, decreased slug migration, development arrests at tipped mound stage, increased protein level |
| DBS0302472 | talB- | talB | abolished autophagic cell death, abolished autophagic vacuole formation |
| DBS0304586 | talB-/ [act15]: talA: GFP | talA, talB | aberrant fruiting body morphology |
| AK244 | tipA- | tipA | decreased gene expression, development arrests at mound stage, increased aggregate size, multiple tips |
| JS56 | tipB- | tipB | development arrests at mound stage, increased aggregate size, multiple tips, multiple tips in mound |
| JS55 | tipC- | tipC | development arrests at mound stage, increased aggregate size, multiple tips |
| JS93 | tipD- | tipD | development arrests at mound stage, increased aggregate size, multiple tips |
| DBS0304519 | tirA- | tirA | decreased growth rate, increased infection rate by Legionella pneumophila |
| DBS0237017 | torA- | torA | decreased cell motility, decreased chemotaxis rate, decreased growth rate, delayed aggregation |
| DBS0237018 | torA-/ [act15]: torA: GFP | torA | abolished growth |
| DBS0237924 | triA- | triA | aberrant culminant morphology, aberrant streaming, aberrant upper cup formation, decreased cell fate commitment, decreased cell fate determination, decreased cell-cell adhesion, decreased spore size, decreased spore viability, increased number of aggregates, increased stalk width |
| DBS0237996 | triA- | triA | aberrant culminant morphology |
| DBS0237997 | triA- | triA | aberrant culminant morphology |
| DBS0237998 | triA-/ [act15]: GFP | triA | aberrant culminant morphology |
| DBS0237999 | triA-/ [ecmAO]: lacZ: [ecmAO]: gus | triA | increased prestalk O cell differentiation |
| DBS0238001 | triA-/ [psA]: lacZ: [psA]: gus | triA | increased prespore cell differentiation |
| DBS0237022 | tsg101- | tsg101 | decreased fruiting body size |
| DBS0302370 | tsuA- | tsuA | aberrant chemotaxis to cAMP, aberrant chemotaxis to folate, abolished cell polarity, decreased aggregate size, decreased fruiting body size, delayed aggregation, increased period of cAMP wave formation |
| DBS0302383 | tsuA-/ [unk]: tsuA(1-1774): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302385 | tsuA-/ [unk]: tsuA(1-260): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302384 | tsuA-/ [unk]: tsuA(1774-2247): YFP | tsuA | abolished localization of protein to microtubules, abolished localization of protein to the microtubule organizing center, decreased aggregate size, decreased fruiting body size |
| DBS0302382 | tsuA-/ [unk]: tsuA(K34R): YFP | tsuA | decreased aggregate size, decreased fruiting body size |
| DBS0302381 | tsuA-/ [unk]: tsuA: YFP | tsuA | wild type |
| DBS0237024 | ubcB- | ubcB | development arrests at mound stage, multiple tips |
| DBS0237025 | ubpA- | ubpA | abolished aggregation, decreased cAMP-induced cAMP pulse, decreased chemotaxis rate, decreased gene expression |
| DBS0237026 | ubpB- | ubpB | aberrant sorus morphology, decreased gene expression, increased gene expression, precocious development |
| DBS0237027 | ufc1- | ufc1 | wild type |
| DBS0266763 | ugpB-/ DH1 | ugpB | decreased stalk length |
| DBS0266764 | ugpB-/ HMX | ugpB | aberrant cell morphology, abolished cellulose biosynthesis, decreased autophagic vacuole formation |
| DBS0237031 | vacA- | vacA | wild type |
| DBS0237032 | vacB- | vacB | decreased exocytosis |
| DBS0237034 | vasP- | vasP | abolished filopodium formation |
| DBS0237035 | vasP- | vasP | aberrant F-actin organization, abolished filopodium formation, decreased cell size, decreased cell-substrate adhesion, decreased chemotaxis rate, decreased filopodium formation, decreased lateral pseudopod suppression |
| DBS0237033 | vasP-/ [act15]: GFP: vasP(1-264/ 285-380) | vasP | abolished filopodium formation |
| DBS0237836 | vasP-/ [act15]: YFP: wipA | vasP, wipA | decreased filopodium formation |
| DBS0237842 | vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG | vasP, wipA | increased filopodium formation |
| DBS0237036 | vasP-/ [act15]: myr: vasP | vasP | aberrant cytokinesis, increased basal F-actin level, increased filopodium formation |
| DBS0237040 | vasP-/ [act15]: vasP | vasP | decreased filopodium formation |
| DBS0237840 | vasP-/ [act15]: vasP | vasP | increased basal F-actin level, increased filopodium formation |
| DBS0237037 | vasP-/ [act15]: vasP(1-110: 231-380) | vasP | aberrant cytokinesis, decreased filopodium formation, increased basal F-actin level |
| DBS0237038 | vasP-/ [act15]: vasP(1-228) | vasP | decreased filopodium formation |
| DBS0237039 | vasP-/ [act15]: vasP(111-380) | vasP | increased basal F-actin level, increased filopodium formation |
| DBS0304927 | vinA- | vinA | wild type |
| DBS0236058 | vmp1- | vmp1 | aberrant aggregation, aberrant response to hypo-osmotic stress, decreased exocytosis, decreased gene expression, decreased growth rate, decreased pinocytosis |
| DG1118 | vps46- | vps46 | increased sorus size |
| DBS0237046 | vwkA- | vwkA | aberrant cytokinesis, aberrant fruiting body morphology, decreased growth rate in suspension, delayed development, increased myosin II assembly, increased protein level |
| TL61 | wacA- | wacA | wild type |
| TL99 | wacA- | wacA | wild type |
| DBS0237048 | warA- | warA | decreased prespore cell differentiation, development arrests at slug stage, increased basal disc size, increased prestalk O cell differentiation |
| DBS0237049 | warA- | warA | decreased prespore cell differentiation, development arrests at slug stage, increased basal disc size, increased prestalk O cell differentiation |
| DG1053 | wimA- | wimA | aberrant fruiting body morphology |
| DG1064 | wimA- | wimA | aberrant fruiting body morphology |
| AK235 | yakA- | yakA | abolished aggregation |
| AK800 | yakA- | yakA | abolished aggregation |
| DBS0237091 | yakA-/ [crlA]: crlA | crlA, yakA | abolished growth |
| DG1014 | yelA- | yelA | aberrant mound color, decreased spore viability, development arrests at mound stage, precocious sporulation |
| ARK100-110 | zakA- | zakA | aberrant fruiting body morphology, decreased gene expression, decreased glycogen synthase kinase 3 activity, decreased sporulation, delayed culmination, increased gene expression |
| DBS0238142 | zakA- | zakA | development arrests at tipped mound stage |
| DG1050 | zipA- | zipA | decreased fruiting body size |
